Market Currents

• Thursday, November 5, 2009

• 08:22 AM Biovail (BVF): Q3 EPS of $0.44 beats by $0.04. Revenue of $212M in-line. (PR) Comment!
• 00:05 AM Notable premarket earnings: ALD, BVF, CAH, CDE, CI, CNQ, CTL, CVS, DNR, DPS, DPTR, DTV, DYN, FTO, GNA, HK, KG, KIM, LAMR, MAC, MF, MGM, NDAQ, OCR, PCS, PXP, RRI, SE, SIRI, SLE, TDC, TWC, WEN, WW Comment!

• Tuesday, September 1, 2009

• 09:00 AM Premarket gainers: NVAX +14%. YRCW +13%. SVA +10%. BONU +9%. BEXP +7%. TXT +6%. HLCS +5%. ALD +5%. GNBT +4%. INO +4%.
  Losers: BEAT -12%. CMED +12%. RMBS -10%. SQNM -9%. IMMU -6%. AXL -6%. CTIC -5%. AIG -5%. CIT -5%. HCN -5%. BVF -4%. Comment!

• Thursday, August 6, 2009

• 07:39 AM Biovail (BVF): Q2 EPS of $0.50 vs. $0.34 consensus (may not be comparable). Revenue of $193.5M (+4%) vs. $191M. (PR) Comment!
• 00:05 AM Notable earnings before Thursday's open: AEE, ARE, BVF, BX, CLR, CMCSA, CNQ, CSE, CSIQ, CTL, DPTR, DSX, DTV, EAT, EP, FTO, FUQI, GLG, GNA, HPT, HUN, IAG, KG, LAMR, LINE, LXP, MF, MPEL, NDAQ, PCS, PXP, SIRI, TDC, TTI, WEN, WIN, WMB, WNR Comment!

• Wednesday, February 4, 2009

• 12:22 PM Shares of Biovail (BVF) showing strength after share sales from founder Eugene Melnyk appear to be over. The Ottawa Senators owner took his stake down to 11% from 13.3% to free up cash, but plans to hold the remainder "for investment purposes." BVF +4.4%. Comment!